We performed flow cytometry for B and T cell markers, including CD3, CD4, CD8, CD19, CD20, and CD16+56, DHR test to rule out CGD, and measured the level of serum immunoglobulins. The gene discussed is CD19; the disease is chronic granulomatous disease.